Loading
Latest filing published 12 Mar 2026 for 비보존 제약, €6,474. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
이현민 (senior executive) discloses dealings in 비보존 제약 to DART (FSS). Over a trading history stretching from 4 December 2025 to 5 March 2026, the count stands at 3 filings.
No open-market sale appears; the market trades are 3 purchases worth €6,474. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 2 purchases and no sales.
The newest entry dates from 12 March 2026: an open-market purchase of €6,474, in 비보존 제약. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations